|
KMID : 0043320180410080823
|
|
Archives of Pharmacal Research
2018 Volume.41 No. 8 p.823 ~ p.829
|
|
|
Simultaneous determination of the bioactive compounds from Sparassis crispa (Wulf.) by HPLC-DAD and their inhibitory effects on LPS-stimulated cytokine production in bone marrow-derived dendritic cell
|
|
Bang Sung-Hee
Lee Chang-Yeol
Ryu Ji-Young
Li Wei
Koh Young-Sang
Jeon Ju-Hyun
Lee Jun
Shim Sang-Hee
|
|
|
Abstract
|
|
|
|
Sparassis crispa (Wulf.) belonging to the family of Sparassidaceae, has been widely used as an edible mushroom due to its unique flavor and functions to improve health. In this study, the compounds isolated from the extract of this mushroom were simultaneously quantified by the developed HPLC-DAD method and evaluated for the inhibitory activities on the production of the LPS-stimulated cytokines (IL-12p40, IL-6, and TNF-α) in bone marrow-derived dendritic cells (BMDCs). The contents of this compounds were 0.1928?±?0.0118, 4.4137?±?0.0240, 0.5237?±?0.0005, 2.7303?±?0.0206 mg/g for sparoside A (1), methyl 2,4-dihydroxy-3-methoxy-6-methylbenzoate (2), sparalide A (3), and 5′-deoxy-5′-methylthioadenosine (4), respectively, which demonstrated that they are the major constituents of this mushroom. Thus, our results were found that the sparoside A (1), 5-hydroxy-7-methoxyphthalide (6), 5-methoxy-7-hydroxyphthalide (7), nicotinamide (10), and adenosine (11) inhibit LPS-stimualted cytokine production, compound 6 is the most potent inhibitory activities on the production of IL-12p40, IL-6, and TNF-α with IC50 values of 0.19, 0.18, and 0.91 μM, respectively.
|
|
|
KEYWORD
|
|
|
Sparassis crispa, HPLC-DAD, Simultaneous determination, Anti-inflammatory
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|